Altana reports semi-annual results: Focus on research and development despite global market presence
Altana presented strong semi-annual results with revenue growing by 3.1% to 1.7 billion euros and Ebitda rising 14.4% to 332 million euros. The company signals its commitment to innovation by investing seven percent of its revenue in R&D. Despite the US being a major market, the portfolio remains globally balanced across America, Europe, and Asia.
The global market for food and nutritional products remains dynamic, and the company Altana has published its latest semi-annual results. These figures underline both solid revenue growth and the company's continued commitment to innovation. Specifically, Altana reports that revenue rose to approximately 1.7 billion euros in the first half of the year, representing an increase of 3.1% compared to the previous year. In parallel, the adjusted profit (Ebitda) recorded a significant increase of 14.4%, reaching 332 million euros.
A central component of the company's strategy remains investment in the future. Altana emphasizes its deep commitment to research and development (R&D) and invests seven percent of its revenue annually for this purpose. This high allocation underlines the focus on technological progress and the further development of products.
Although the United States of America (USA) represents the largest market for Altana with one-fifth of the total revenue, the company's overall portfolio is characterized by a globally balanced distribution. Business operations are broadly established in America, Europe, and Asia, making the company resilient to regional market fluctuations and thus signaling a stable basis for further international growth.